Skip to content
OpenCapital
Get started

Viking Therapeutics VKTX Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$12.01B+64.2%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$3.8B+21.9%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.78B+300%

Other financials

Income statement

See full
Revenue-—
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0×0.0×
Current ratio5.7×-38.5×

Where this comes from

Computed from the period-end share price: $3.76B.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's market capitalization?
Viking Therapeutics (VKTX) reported market capitalization of $3.76B in Q1 2026.
How has Viking Therapeutics's market capitalization changed year-over-year?
Viking Therapeutics's market capitalization increased by 38.7% year-over-year, from $2.71B to $3.76B.
What is the long-term trend for Viking Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Viking Therapeutics's market capitalization has grown at a 55.3% compound annual growth rate (CAGR), from $440.46M to $3.98B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.